Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 326639
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Bio Contract Development and Manufacturing Organizations (CDMOs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Bio Contract Development and Manufacturing Organizations (CDMOs) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pharmaceutical Company accounting for % of the Bio Contract Development and Manufacturing Organizations (CDMOs) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While API Development segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Bio Contract Development and Manufacturing Organizations (CDMOs) include Lonza, Boehringer ‎Ingelheim, Celltrion, Fujifilm, and Selexis, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Bio Contract Development and Manufacturing Organizations (CDMOs) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

API Development

Manufacturing

Drug Delivery

Market segment by Application, can be divided into

Pharmaceutical Company

Biotechnology Company

Generic Company

Market segment by players, this report covers

Lonza

Boehringer ‎Ingelheim

Celltrion

Fujifilm

Selexis

Ology Bio

Ardena

Catalent

AGC

Amgen

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Bio Contract Development and Manufacturing Organizations (CDMOs) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Bio Contract Development and Manufacturing Organizations (CDMOs), with revenue, gross margin and global market share of Bio Contract Development and Manufacturing Organizations (CDMOs) from 2019 to 2022.

Chapter 3, the Bio Contract Development and Manufacturing Organizations (CDMOs) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Bio Contract Development and Manufacturing Organizations (CDMOs) market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Bio Contract Development and Manufacturing Organizations (CDMOs) research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Bio Contract Development and Manufacturing Organizations (CDMOs)

1.2 Classification of Bio Contract Development and Manufacturing Organizations (CDMOs) by Type

1.2.1 Overview: Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type in 2021

1.2.3 API Development

1.2.4 Manufacturing

1.2.5 Drug Delivery

1.3 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market by Application

1.3.1 Overview: Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Pharmaceutical Company

1.3.3 Biotechnology Company

1.3.4 Generic Company

1.4 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size & Forecast

1.5 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast by Region

1.5.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region, (2017-2022)

1.5.3 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Prospect (2017-2028)

1.5.4 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Prospect (2017-2028)

1.5.6 South America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Drivers

1.6.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Restraints

1.6.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Trends Analysis

2 Company Profiles

2.1 Lonza

2.1.1 Lonza Details

2.1.2 Lonza Major Business

2.1.3 Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

2.1.4 Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Lonza Recent Developments and Future Plans

2.2 Boehringer ‎Ingelheim

2.2.1 Boehringer ‎Ingelheim Details

2.2.2 Boehringer ‎Ingelheim Major Business

2.2.3 Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

2.2.4 Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Boehringer ‎Ingelheim Recent Developments and Future Plans

2.3 Celltrion

2.3.1 Celltrion Details

2.3.2 Celltrion Major Business

2.3.3 Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

2.3.4 Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Celltrion Recent Developments and Future Plans

2.4 Fujifilm

2.4.1 Fujifilm Details

2.4.2 Fujifilm Major Business

2.4.3 Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

2.4.4 Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Fujifilm Recent Developments and Future Plans

2.5 Selexis

2.5.1 Selexis Details

2.5.2 Selexis Major Business

2.5.3 Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

2.5.4 Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Selexis Recent Developments and Future Plans

2.6 Ology Bio

2.6.1 Ology Bio Details

2.6.2 Ology Bio Major Business

2.6.3 Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

2.6.4 Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Ology Bio Recent Developments and Future Plans

2.7 Ardena

2.7.1 Ardena Details

2.7.2 Ardena Major Business

2.7.3 Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

2.7.4 Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Ardena Recent Developments and Future Plans

2.8 Catalent

2.8.1 Catalent Details

2.8.2 Catalent Major Business

2.8.3 Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

2.8.4 Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Catalent Recent Developments and Future Plans

2.9 AGC

2.9.1 AGC Details

2.9.2 AGC Major Business

2.9.3 AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

2.9.4 AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 AGC Recent Developments and Future Plans

2.10 Amgen

2.10.1 Amgen Details

2.10.2 Amgen Major Business

2.10.3 Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

2.10.4 Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Amgen Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Bio Contract Development and Manufacturing Organizations (CDMOs) Players Market Share in 2021

3.2.2 Top 10 Bio Contract Development and Manufacturing Organizations (CDMOs) Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Players Head Office, Products and Services Provided

3.4 Bio Contract Development and Manufacturing Organizations (CDMOs) Mergers & Acquisitions

3.5 Bio Contract Development and Manufacturing Organizations (CDMOs) New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Market Share by Type (2017-2022)

4.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Application (2017-2022)

5.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2017-2028)

6.2 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2017-2028)

6.3 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country

6.3.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2017-2028)

6.3.2 United States Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

6.3.3 Canada Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

6.3.4 Mexico Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2017-2028)

7.2 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2017-2028)

7.3 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country

7.3.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2017-2028)

7.3.2 Germany Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

7.3.3 France Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

7.3.5 Russia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

7.3.6 Italy Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2017-2028)

8.2 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2017-2028)

8.3 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region

8.3.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Region (2017-2028)

8.3.2 China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

8.3.3 Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

8.3.4 South Korea Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

8.3.5 India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

8.3.7 Australia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2017-2028)

9.2 South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2017-2028)

9.3 South America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country

9.3.1 South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2017-2028)

9.3.2 Brazil Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

9.3.3 Argentina Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2017-2028)

10.2 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2017-2028)

10.3 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country

10.3.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2017-2028)

10.3.2 Turkey Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

10.3.4 UAE Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million) by Region (2017-2022)

Table 5. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Region (2023-2028)

Table 6. Lonza Corporate Information, Head Office, and Major Competitors

Table 7. Lonza Major Business

Table 8. Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

Table 9. Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Boehringer ‎Ingelheim Corporate Information, Head Office, and Major Competitors

Table 11. Boehringer ‎Ingelheim Major Business

Table 12. Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

Table 13. Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Celltrion Corporate Information, Head Office, and Major Competitors

Table 15. Celltrion Major Business

Table 16. Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

Table 17. Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Fujifilm Corporate Information, Head Office, and Major Competitors

Table 19. Fujifilm Major Business

Table 20. Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

Table 21. Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Selexis Corporate Information, Head Office, and Major Competitors

Table 23. Selexis Major Business

Table 24. Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

Table 25. Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Ology Bio Corporate Information, Head Office, and Major Competitors

Table 27. Ology Bio Major Business

Table 28. Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

Table 29. Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Ardena Corporate Information, Head Office, and Major Competitors

Table 31. Ardena Major Business

Table 32. Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

Table 33. Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Catalent Corporate Information, Head Office, and Major Competitors

Table 35. Catalent Major Business

Table 36. Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

Table 37. Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. AGC Corporate Information, Head Office, and Major Competitors

Table 39. AGC Major Business

Table 40. AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

Table 41. AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Amgen Corporate Information, Head Office, and Major Competitors

Table 43. Amgen Major Business

Table 44. Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions

Table 45. Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Bio Contract Development and Manufacturing Organizations (CDMOs) by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Bio Contract Development and Manufacturing Organizations (CDMOs) Players Head Office, Products and Services Provided

Table 50. Bio Contract Development and Manufacturing Organizations (CDMOs) Mergers & Acquisitions in the Past Five Years

Table 51. Bio Contract Development and Manufacturing Organizations (CDMOs) New Entrants and Expansion Plans

Table 52. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million) by Type (2017-2022)

Table 53. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Type (2017-2022)

Table 54. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Forecast by Type (2023-2028)

Table 55. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2017-2022)

Table 56. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Forecast by Application (2023-2028)

Table 57. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Bio Contract Development and Manufacturing Organizations (CDMOs) Picture

Figure 2. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type in 2021

Figure 3. API Development

Figure 4. Manufacturing

Figure 5. Drug Delivery

Figure 6. Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Application in 2021

Figure 7. Pharmaceutical Company Picture

Figure 8. Biotechnology Company Picture

Figure 9. Generic Company Picture

Figure 10. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Region (2017-2028)

Figure 13. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Region in 2021

Figure 14. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Drivers

Figure 20. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Restraints

Figure 21. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Trends

Figure 22. Lonza Recent Developments and Future Plans

Figure 23. Boehringer ‎Ingelheim Recent Developments and Future Plans

Figure 24. Celltrion Recent Developments and Future Plans

Figure 25. Fujifilm Recent Developments and Future Plans

Figure 26. Selexis Recent Developments and Future Plans

Figure 27. Ology Bio Recent Developments and Future Plans

Figure 28. Ardena Recent Developments and Future Plans

Figure 29. Catalent Recent Developments and Future Plans

Figure 30. AGC Recent Developments and Future Plans

Figure 31. Amgen Recent Developments and Future Plans

Figure 32. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Players in 2021

Figure 33. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 34. Global Top 3 Players Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share in 2021

Figure 35. Global Top 10 Players Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share in 2021

Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 37. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Type in 2021

Figure 38. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share Forecast by Type (2023-2028)

Figure 39. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Application in 2021

Figure 40. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share Forecast by Application (2023-2028)

Figure 41. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share by Type (2017-2028)

Figure 42. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share by Application (2017-2028)

Figure 43. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Country (2017-2028)

Figure 44. United States Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Canada Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Mexico Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share by Type (2017-2028)

Figure 48. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share by Application (2017-2028)

Figure 49. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Country (2017-2028)

Figure 50. Germany Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. France Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. United Kingdom Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Russia Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Italy Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share by Type (2017-2028)

Figure 56. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share by Application (2017-2028)

Figure 57. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Region (2017-2028)

Figure 58. China Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. South Korea Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. India Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Australia Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share by Type (2017-2028)

Figure 65. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share by Application (2017-2028)

Figure 66. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Country (2017-2028)

Figure 67. Brazil Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Argentina Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share by Type (2017-2028)

Figure 70. Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share by Application (2017-2028)

Figure 71. Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Country (2017-2028)

Figure 72. Turkey Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Saudi Arabia Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. UAE Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Methodology

Figure 76. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz